Indeed, Chang et al. designed a chimeric receptor termed NKG2D-DAP10- CD3ζ to retrovirally transduce NK cells which became consistently more cytotoxic and produced more cytokines than mock-transduced cells against leukemia and solid tumor cell lines. Here, KLRK1 is linked to leukemia.